Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob Pieters

Showing results (261-270 of 336) with videos related to

Pageof 34
Sort By:
Pediatric Blood & Cancer|November 20, 2014
Decreased induction morbidity and mortality following modification to induction therapy in infants with acute lymphoblastic leukemia enrolled on AALL0631: a report from the Children's Oncology GroupWanda L Salzer, Tamekia L Jones, Meenakshi Devidas, et al.
Blood|August 7, 2009
Outcome of congenital acute lymphoblastic leukemia treated on the Interfant-99 protocolMarieke H van der Linden, Maria Grazia Valsecchi, Paola De Lorenzo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2026
Sustained Benefit of Blinatumomab in Infants With <i>KMT2A</i>-Rearranged ALL: Long-Term Outcomes, Toxicity, and PharmacokineticsMiguel Vieira Martins, Paola de Lorenzo, Rishi S Kotecha, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2016
Hydrocortisone as an Intervention for Dexamethasone-Induced Adverse Effects in Pediatric Patients With Acute Lymphoblastic Leukemia: Results of a Double-Blind, Randomized Controlled TrialLidewij T Warris, Marry M van den Heuvel-Eibrink, Femke K Aarsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2013
Dasatinib in children and adolescents with relapsed or refractory leukemia: results of the CA180-018 phase I dose-escalation study of the Innovative Therapies for Children with Cancer ConsortiumC Michel Zwaan, Carmelo Rizzari, Francoise Mechinaud, et al.
Oncotarget|November 29, 2016
Tyrosine kinase fusion genes in pediatric BCR-ABL1-like acute lymphoblastic leukemiaJudith M Boer, Elisabeth M P Steeghs, João R M Marchante, et al.
Oncotarget|November 23, 2017
<i>JAK2</i> aberrations in childhood B-cell precursor acute lymphoblastic leukemiaElisabeth M P Steeghs, Isabel S Jerchel, Willemieke de Goffau-Nobel, et al.
BMC Pediatrics|May 11, 2017
TropicALL study: Thromboprophylaxis in Children treated for Acute Lymphoblastic Leukemia with Low-molecular-weight heparin: a multicenter randomized controlled trialIrene L M Klaassen, Mandy N Lauw, Marianne D van de Wetering, et al.
Lancet (London, England)|July 31, 2007
A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trialRob Pieters, Martin Schrappe, Paola De Lorenzo, et al.
British Journal of Haematology|February 23, 2016
New cellular markers at diagnosis are associated with isolated central nervous system relapse in paediatric B-cell precursor acute lymphoblastic leukaemiaVincent H J van der Velden, Daphne de Launaij, Jeltje F de Vries, et al.
Pageof 34

Showing results (261-270 of 336) with videos related to

Sort By:
Pageof 34
Pediatric Blood & Cancer|November 20, 2014
Decreased induction morbidity and mortality following modification to induction therapy in infants with acute lymphoblastic leukemia enrolled on AALL0631: a report from the Children's Oncology GroupWanda L Salzer, Tamekia L Jones, Meenakshi Devidas, et al.
Blood|August 7, 2009
Outcome of congenital acute lymphoblastic leukemia treated on the Interfant-99 protocolMarieke H van der Linden, Maria Grazia Valsecchi, Paola De Lorenzo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2026
Sustained Benefit of Blinatumomab in Infants With <i>KMT2A</i>-Rearranged ALL: Long-Term Outcomes, Toxicity, and PharmacokineticsMiguel Vieira Martins, Paola de Lorenzo, Rishi S Kotecha, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2016
Hydrocortisone as an Intervention for Dexamethasone-Induced Adverse Effects in Pediatric Patients With Acute Lymphoblastic Leukemia: Results of a Double-Blind, Randomized Controlled TrialLidewij T Warris, Marry M van den Heuvel-Eibrink, Femke K Aarsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2013
Dasatinib in children and adolescents with relapsed or refractory leukemia: results of the CA180-018 phase I dose-escalation study of the Innovative Therapies for Children with Cancer ConsortiumC Michel Zwaan, Carmelo Rizzari, Francoise Mechinaud, et al.
Oncotarget|November 29, 2016
Tyrosine kinase fusion genes in pediatric BCR-ABL1-like acute lymphoblastic leukemiaJudith M Boer, Elisabeth M P Steeghs, João R M Marchante, et al.
Oncotarget|November 23, 2017
<i>JAK2</i> aberrations in childhood B-cell precursor acute lymphoblastic leukemiaElisabeth M P Steeghs, Isabel S Jerchel, Willemieke de Goffau-Nobel, et al.
BMC Pediatrics|May 11, 2017
TropicALL study: Thromboprophylaxis in Children treated for Acute Lymphoblastic Leukemia with Low-molecular-weight heparin: a multicenter randomized controlled trialIrene L M Klaassen, Mandy N Lauw, Marianne D van de Wetering, et al.
Lancet (London, England)|July 31, 2007
A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trialRob Pieters, Martin Schrappe, Paola De Lorenzo, et al.
British Journal of Haematology|February 23, 2016
New cellular markers at diagnosis are associated with isolated central nervous system relapse in paediatric B-cell precursor acute lymphoblastic leukaemiaVincent H J van der Velden, Daphne de Launaij, Jeltje F de Vries, et al.
Pageof 34